Glaucoma Trial, Recruiting NCT06124521 Sponsor: University of Michigan Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06124521
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as Black or African American
  • People who have already completed the screening examination part of this study

Who may not be able to join:

  • People who are currently experiencing severe eye pain rated higher than 8 out of 10
  • People who have had a sudden loss of vision within the past week
  • People who are seeing double in a way that does not go away when blinking, regardless of which eye is covered (seeing two separate objects, not blurry vision)
  • People who are pregnant
  • People who are currently incarcerated
  • People who are unable to describe their eye health or personal living situation due to a cognitive impairment
  • People who are planning to move outside of Michigan, or outside of driving distance to the church location, within the next 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angela Elam, University of Michigan

Phone: 734-945-6046

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 October 2024
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Eye care utilization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov